These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 24360654)
1. Fluorescence in situ hybridization for diagnosis of cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Navaneethan U; Njei B; Venkatesh PG; Vargo JJ; Parsi MA Gastrointest Endosc; 2014 Jun; 79(6):943-950.e3. PubMed ID: 24360654 [TBL] [Abstract][Full Text] [Related]
2. Diagnostic yield of bile duct brushings for cholangiocarcinoma in primary sclerosing cholangitis: a systematic review and meta-analysis. Trikudanathan G; Navaneethan U; Njei B; Vargo JJ; Parsi MA Gastrointest Endosc; 2014 May; 79(5):783-9. PubMed ID: 24140129 [TBL] [Abstract][Full Text] [Related]
3. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma. Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis. Quinn KP; Tabibian JH; Lindor KD Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204 [TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Njei B; McCarty TR; Varadarajulu S; Navaneethan U Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1139-1151. PubMed ID: 27696456 [TBL] [Abstract][Full Text] [Related]
6. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens. Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638 [TBL] [Abstract][Full Text] [Related]
7. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma. Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989 [TBL] [Abstract][Full Text] [Related]
8. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis. Jesudian AB; Jacobson IM Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124 [TBL] [Abstract][Full Text] [Related]
13. Cost utility of ERCP-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Njei B; McCarty TR; Varadarajulu S; Navaneethan U Gastrointest Endosc; 2017 Apr; 85(4):773-781.e10. PubMed ID: 27590963 [TBL] [Abstract][Full Text] [Related]
14. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience. Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791 [TBL] [Abstract][Full Text] [Related]
15. "FISHing" for an accurate diagnostic test for cholangiocarcinoma. Koro NS; Elmunzer BJ; Coté GA Gastroenterology; 2015 Mar; 148(3):655-7. PubMed ID: 25625763 [No Abstract] [Full Text] [Related]
16. Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study. Navaneethan U; Parsi MA; Lourdusamy V; Bhatt A; Gutierrez NG; Grove D; Sanaka MR; Hammel JP; Stevens T; Vargo JJ; Dweik RA Gastrointest Endosc; 2015 Apr; 81(4):943-9.e1. PubMed ID: 25500329 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis. von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030 [TBL] [Abstract][Full Text] [Related]
18. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720 [TBL] [Abstract][Full Text] [Related]
19. Cholangioscopy Biopsies Improve Detection of Cholangiocarcinoma When Combined with Cytology and FISH, but Not in Patients with PSC. Kaura K; Sawas T; Bazerbachi F; Storm AC; Martin JA; Gores GJ; Abu Dayyeh BK; Topazian MD; Levy MJ; Petersen BT; Chandrasekhara V Dig Dis Sci; 2020 May; 65(5):1471-1478. PubMed ID: 31571103 [TBL] [Abstract][Full Text] [Related]
20. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma. Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]